NRIX EPS Estimates
Nurix Therapeutics, Inc.
$16.14
+$0.84(+5.49%)
42
Overall
60
Value
18
Tech
50
Quality
Market Cap
$1.76B
Volume
5.97M
52W Range
$12.01 - $28.23
Target Price
$33.50
NRIX EPS estimates: the consensus estimate for Nurix Therapeutics, Inc.'s current fiscal year is $1.14 per share. Quarterly and next-year EPS forecasts, growth estimates and revenue projections follow.
NRIX EPS Estimates
- EPS estimate, current quarter
- $-0.46
- EPS estimate, next quarter
- $-0.47
- EPS estimate, current year
- $1.14
- EPS estimate, next year
- $-2.07
- EPS growth, 3-year
- +1.35%
| Fiscal year | EPS |
|---|---|
| 2024 | $-2.88 |
| 2023 | $-2.65 |
| 2022 | $-3.71 |
| 2021 | $-2.73 |
| 2020 | $-2.76 |
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | NRIX | $16.14 | +5.5% | 5.97M |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get Nurix Therapeutics, Inc. Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW